Search research articles
Contact Us
Filters
Showing results (131-140 of 289) with videos related to
Page
of 29
Sort By:
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 18, 1975
Analgesic renal papillary necrosis
J D Smith, R Rabkin, D Stables, et al.
Postgraduate Medical Journal
|
March 1, 1982
Treatment of small cell lung carcinoma in association with cryptogenic fibrosing alveolitis
J R Lipton, J Winstanley, K Carroll, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 24, 2005
Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments
C Faivre-Finn, L W Lee, P Lorigan, et al.
British Journal of Cancer
|
June 1, 1993
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer
H Anderson, P Hopwood, J Prendiville, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
A phase I toxicity study of human rDNA interferon in patients with solid tumours
J Wagstaff, G Chadwick, A Howell, et al.
Cancer Research
|
February 1, 1989
Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma
M J Lind, J M Margison, T Cerny, et al.
British Journal of Cancer
|
August 22, 2002
Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival results
J A Burgers, A Arance, L Ashcroft, et al.
Carcinogenesis
|
April 1, 1996
Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumors: possible significance in nitrosourea therapy
S M Lee, H Reid, R H Elder, et al.
British Journal of Cancer
|
December 1, 1995
Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study
D C Betticher, H Anderson, M Ranson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution
M J Lind, J M Margison, T Cerny, et al.
Page
of 29
Search research articles
Search
Showing results (131-140 of 289) with videos related to
Sort By:
Page
of 29
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 18, 1975
Analgesic renal papillary necrosis
J D Smith, R Rabkin, D Stables, et al.
Postgraduate Medical Journal
|
March 1, 1982
Treatment of small cell lung carcinoma in association with cryptogenic fibrosing alveolitis
J R Lipton, J Winstanley, K Carroll, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 24, 2005
Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments
C Faivre-Finn, L W Lee, P Lorigan, et al.
British Journal of Cancer
|
June 1, 1993
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer
H Anderson, P Hopwood, J Prendiville, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
A phase I toxicity study of human rDNA interferon in patients with solid tumours
J Wagstaff, G Chadwick, A Howell, et al.
Cancer Research
|
February 1, 1989
Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma
M J Lind, J M Margison, T Cerny, et al.
British Journal of Cancer
|
August 22, 2002
Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival results
J A Burgers, A Arance, L Ashcroft, et al.
Carcinogenesis
|
April 1, 1996
Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumors: possible significance in nitrosourea therapy
S M Lee, H Reid, R H Elder, et al.
British Journal of Cancer
|
December 1, 1995
Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study
D C Betticher, H Anderson, M Ranson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution
M J Lind, J M Margison, T Cerny, et al.
Page
of 29